a decreasing trendP < 0.05
Bisoprolol was the most prescribed cardioselective β-blocker with a decreasing trend from stage I (100%) to stage IV (50%), P < 0.05.
Bisoprolol was the most prescribed cardioselective β-blocker with a decreasing trend from stage I (100%) to stage IV (50%), P < 0.05.